Key result
Carotid aneurysm stenting followed 11 years later by fatal sarcoma in the thrombosed sac.
Why the study?
Primary undifferentiated sarcomas associated with aneurysm sacs are extremely rare, and intracranial involvement is exceptional and poorly documented.
Case Report (n=1)
No
This case documents the first reported high-grade undifferentiated sarcoma arising within a stent-treated intracranial carotid aneurysm sac 11 years post-procedure, highlighting diagnostic challenges of atypical masses in treated vascular territories.
Answers are grounded in this paper and cite their sources.
Rare sarcoma in stented aneurysm sac warrants vigilance for atypical masses; leaves open potential stent-related oncogenesis.
BACKGROUND: Undifferentiated soft tissue sarcomas are rare tumors lacking identifiable differentiation. Primary sarcomas associated with aneurysm sacs are extremely rare, typically involving large vessels. Intracranial involvement is exceptional and poorly documented. OBSERVATIONS: The authors report the case of a patient treated in 2009 for a left paraclinoid internal carotid artery aneurysm (18 × 10 mm) by endovascular stenting (Silk 4.5/30). Eleven years later, he developed headache, somnolence, visual blurring, left ptosis, and anisocoria. CT and CTA showed the known thrombosed aneurysm and an adjacent hypervascular midline lesion. Angiography confirmed complete exclusion with a patent stent and no new aneurysms. MRI revealed a suprasellar-retrosellar multilobulated enhancing mass causing marked brainstem compression. Surgery identified a solid lesion seemingly arising along the thrombosed aneurysm sac, and partial resection was performed. The patient initially recovered but subsequently deteriorated with rapid tumor regrowth and died during hospitalization. Histological analysis showed a grade 3 undifferentiated sarcoma (vimentin +, MDM2+, focal smooth muscle actin -, CAM5.2-, GFAP-). Postmortem examination confirmed origin within the aneurysm sac adjacent to the stent. LESSONS: To the authors' knowledge, this is the first reported undifferentiated sarcoma arising from a stent-treated carotid aneurysm. Although causality cannot be established, it parallels rare stent-associated sarcomas in large vessels and highlights the diagnostic challenges of atypical masses in treated vessels. https://thejns.org/doi/10.3171/CASE26659.
No takes yet. Share an insight, caveat, or question.
Scalise et al. (2026) conducted a case report in Grade 3 undifferentiated sarcoma arising from a stent-treated left paraclinoid internal carotid artery aneurysm (n=1). Endovascular flow-diverting stenting (Silk 4.5/30) followed by surgical partial resection via craniotomy was evaluated on Development of grade 3 undifferentiated sarcoma and subsequent in-hospital mortality. Endovascular stenting of an internal carotid artery aneurysm was followed 11 years later by a fatal grade 3 undifferentiated sarcoma arising from the thrombosed aneurysm sac.
Synapse has enriched 10 related papers. Consider them for comparative context: